Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Oligodendroglioma × Vincristine × Clear all

Phase

Status

Completed 8 Unknown 3 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 18 Burkitt Lymphoma 13 Lymphoma, Large B-Cell, Diffuse 10 Lymphoma, Follicular 7 Lymphoma, B-Cell 7 Rhabdomyosarcoma 6 Neuroblastoma 5 Lymphoma, T-Cell, Peripheral 5 Leukemia, Biphenotypic, Acute 5 Lymphoma 4 Sarcoma, Ewing 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Non-Hodgkin 3 Wilms Tumor 2 Sarcoma 2 Retinoblastoma 2 Recurrence 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2 Plasmablastic Lymphoma 2 Osteosarcoma 2 Medulloblastoma 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, B-Cell 2 Hodgkin Disease 2 Blastic Plasmacytoid Dendritic Cell Neoplasm 2 Stage I Mixed Cell Type Kidney Wilms Tumor 1 Rhabdomyosarcoma, Embryonal 1 Pleuropulmonary blastoma 1 Pediatric Solid Tumor 1 Optic Nerve Glioma 1

Interventions

Temozolomide 5 Radiotherapy 5 Bevacizumab 2 tislelizumab 1 olutasidenib 1 abexinostat 1 Vincristine 1 Tretinoin 1 Radiation 1 Procarbazine 1 ONC206 1 Lomustine 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05331521 2026-02-03

ImproveCodel

University Hospital Heidelberg

Phase 3 Recruiting

Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡